IDH1 and glioma: Interestingly, G0S2 mutations were not reported in 1102 gliomas among TCGA WHO grade II–IV gliomas (Fig 1D), supporting the notion that G0S2 is epigenetically silenced in gliomas harboring IDH1 mutations.